Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team
Third party research

Gabather: Key shareholders show support - VH Corp

Gabather

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
* A directed share issue adds MSEK 4.2 before costs
* First patient enrolment expected as next trigger
* We keep our fair value of SEK 0.06 per share

Gabather has carried out a directed share issue of approximately MSEK 4.2 with
participation from several investors, improving the company’s cash position.
Together with earlier warrant exercises and improved cost control, this
reduces financial risk and extends the funding runway. Further progress
updates on the phase II clinical trial of GT-002 in Denmark are awaited.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.